These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35525925)

  • 1. Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.
    Razavi H; Katanforosh A
    BMC Genomics; 2022 May; 23(1):352. PubMed ID: 35525925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
    Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the long noncoding RNA expression profile and construction of the lncRNA-mRNA co-expression network in colorectal cancer.
    Zhang Q; Ding Z; Wan L; Tong W; Mao J; Li L; Hu J; Yang M; Liu B; Qian X
    Cancer Biol Ther; 2020; 21(2):157-169. PubMed ID: 31619123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
    Wang M; Feng Z; Li X; Sun S; Lu L
    Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
    Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
    Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
    Li X; Xiao X; Chang R; Zhang C
    J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomethylation of the lncRNA SOX21-AS1 has clinical prognostic value in cervical cancer.
    Wang R; Li Y; Du P; Zhang X; Li X; Cheng G
    Life Sci; 2019 Sep; 233():116708. PubMed ID: 31369759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer.
    Yang CM; Wang TH; Chen HC; Li SC; Lee MC; Liou HH; Liu PF; Tseng YK; Shiue YL; Ger LP; Tsai KW
    Clin Epigenetics; 2016; 8():129. PubMed ID: 27933111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
    J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance.
    Lu L; Yu M; Huang W; Chen H; Jiang G; Li G
    Libyan J Med; 2023 Dec; 18(1):2220153. PubMed ID: 37300839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA HOXC-AS1 promotes gastric cancer via binding eIF4AIII by activating Wnt/β-catenin signaling.
    Zhou C; An N; Cao C; Wang G
    J Gene Med; 2020 Sep; 22(9):e3202. PubMed ID: 32307743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
    Zha Z; Zhang P; Li D; Liu G; Lu L
    Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Methylation of the SOX21-AS1 Promoter Region Promotes Gene Expression and Its Clinical Value in Cervical Cancer.
    Du P; Zhi Y; Wang R; Li Y; Li H; Zhang X; Cheng G; Li X
    Reprod Sci; 2021 Feb; 28(2):532-540. PubMed ID: 33095426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
    Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
    Liu Z; Liu Q; Wang X; Liu L; Shi L; Li H
    Dis Markers; 2022; 2022():6106503. PubMed ID: 36118668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.